Key result
ELCA achieves ~97% procedural success overall, with fewer long-term revascularizations in calcified de novo lesions.
Why the study?
Excimer laser coronary atherectomy (ELCA) is a debulking option for complex coronary lesions, and this study evaluated differences in procedural, in-hospital, and long-term outcomes between patients treated for calcified de novo lesions (CDNL) and intrastent restenosis (ISR).
Does excimer laser coronary atherectomy result in different procedural, in-hospital, and long-term outcomes in patients with calcified de novo lesions compared with intrastent restenosis?
Cohort (n=320)
Yes
Does excimer laser coronary atherectomy result in different procedural, in-hospital, and long-term outcomes in patients with calcified de novo lesions compared with intrastent restenosis?
In the multicenter ACCELERATE registry, excimer laser coronary atherectomy demonstrated high procedural success (97%) in complex coronary lesions and suggested superior long-term outcomes with lower target lesion revascularization in calcified de novo lesions compared with intrastent restenosis.
Answers are grounded in this paper and cite their sources.
Registry insights on ELCA in complex PCI are hypothesis-generating; randomized trials needed before practice change.
Excimer laser coronary atherectomy (ELCA) is a debulking option for treating complex coronary lesions. Recently, interesting clinical data came to the light from a multi-center prospectical study (the ACCELERATE Registry) which enrolled 320 consecutive patients treated with ELCA. The aim of the present study is to evaluate the differences in terms of procedural, in-hospital and long-term outcomes between patients treated for calcified de novo lesions (CDNL) and intrastent restenosis (ISR) in the ACCELERATE Registry. Between July 2018 and May 2024, 320 consecutive patients (mean age 71 ± 9 years) with 429 lesions treated with ELCA were included in the registry. Among them, 156 patients had 197 CDNL, while 164 patients had 232 ISR, with 205 cases due to neointimal proliferation and 27 cases to stent under-expansion. The cohort was characterized by high anatomical complexity and an elevated cardiovascular risk, with a Syntax score of 20.00 ± 10.2 and an STS score of 2.8 ± 2.3. Procedural success was achieved in 97% of cases (99% CDNL vs. 95.1% ISR), and complete revascularization was performed in 74% of cases. In conclusion the results of this study confirm safety and effectiveness of ELCA in treating complex coronary lesions and suggest that ELCA may offer superior long-term outcomes in patients with CDNL compared with ISR, particularly in reducing the incidence of TLR at long-term follow up.
No takes yet. Share an insight, caveat, or question.
Tomasello et al. (2026) conducted a cohort in Complex coronary lesions (calcified de novo lesions and intrastent restenosis) treated with excimer laser coronary atherectomy (n=320). Excimer laser coronary atherectomy (ELCA) for calcified de novo lesions (CDNL) vs. Excimer laser coronary atherectomy (ELCA) for intrastent restenosis (ISR) was evaluated on Procedural success. Excimer laser coronary atherectomy achieved 97% overall procedural success and reduced long-term TLR in CDNL.
Synapse has enriched 10 related papers. Consider them for comparative context: